Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates

ClinicalTrials.gov ID: NCT06075745

Public ClinicalTrials.gov record NCT06075745. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 1:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates (CTOT-44)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-center clinical trial in Cytomegalovirus (CMV) seronegative prospective liver transplant recipients to determine the efficacy of two doses of Cytomegalovirus-Modified Vaccinia Ankara (CMV-MVA) Triplex CMV vaccine pre-transplant. The primary objective is to assess the effect of pre-transplant (Tx) Triplex vaccination on duration of CMV antiviral therapy (AVT) within the first 100 days post-Tx in CMV seropositive donor (D+) and seronegative (R-) (D+R-) liver transplant recipients (LTxRs). A protocol-mandated preemptive therapy (PET) will be used for CMV disease prevention in D+R- LTxRs.

Study identification

NCT ID
NCT06075745
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Enrollment
416 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 4, 2024
Primary completion
Jun 29, 2027
Completion
Feb 27, 2028
Last update posted
Jul 23, 2026

2024 – 2028

United States locations

U.S. sites
18
U.S. states
15
U.S. cities
18
Facility City State ZIP Site status
University of Alabama at Birmingham, School of Medicine Birmingham Alabama 35233 Withdrawn
University of California, San Diego School of Medicine La Jolla California 92093 Recruiting
Stanford University Redwood City California 94063-3126 Recruiting
University of California, San Francisco San Francisco California 94143-0000 Recruiting
University of Miami, Jackson Memorial Hospital Miami Florida 33136-1003 Recruiting
Emory University Hospital Atlanta Georgia 30322-0000 Recruiting
Northwestern University, Feinberg School of Medicine Chicago Illinois 60611-0000 Recruiting
Johns Hopkins University School of Medicine Baltimore Maryland 21205-0000 Recruiting
University of Michigan Medical Center Ann Arbor Michigan 48109-1274 Recruiting
Mayo Clinic, Rochester - College of Medicine and Science Rochester Minnesota 55905-0001 Recruiting
University of Nebraska Medical Center Omaha Nebraska 68198-7835 Recruiting
Duke University School of Medicine Durham North Carolina 27710-1000 Recruiting
Oregon Health & Sciences University Portland Oregon 97239-3098 Recruiting
University of Pennsylvania School of Medicine Philadelphia Pennsylvania 19104-5127 Recruiting
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213-0000 Recruiting
Vanderbilt University School of Medicine Nashville Tennessee 37232-0011 Recruiting
University of Texas Southwestern Medical Center Dallas Texas 75390-0000 Recruiting
University of Washington Medical Center: Transplantation Seattle Washington 98195 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06075745, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2026 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06075745 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →